The winner of the Venture Challenge Spring 2019 is AmbAgon
First-in-class drugs through targeted stabilisation of protein complexes During the Dutch Biotech Event where biotech companies of…
First-in-class drugs through targeted stabilisation of protein complexes During the Dutch Biotech Event where biotech companies of…
Snelle diagnose en passende behandeling met SpiroNose Binnen enkele minuten kan de elektronische neus “SpiroNose” op basis van…
MyLife Technologies started a first-in-human study with its ceramic nanoporous MicroNeedle Arrays (npMNA) technology at Centre for…
You are ready to start your business, however, is the University or Medical Center ready as well…
Recent Comments